NDC 60505-4858-03 - Tofacitinib
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60505-4858
- Requested NDC
- 60505-4858-03
- Package NDCs from labels
- 60505-4858-3, 60505-4858-03
- Manufacturer
- Apotex Corp.
- Effective date
- 2026-10-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Tofacitinib - Apotex Corp. | Apotex Corp. | 2026-10-08 | HUMAN PRESCRIPTION DRUG LABEL |
| Tofacitinib - AvKARE | AvKARE | 2026-06-24 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tofacitinib | TOFACITINIB | XLCare Pharmaceuticals Inc | 10403307-e2f9-44d1-bc72-552fdba299d1 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| Mannitol | MANNITOL | Henry Schein, Inc. | e2444db1-9dfe-451f-a33c-9b00786464d2 | 2026-11-02 | Warnings, Adverse reactions | 3OWL53L36A |
| Tofacitinib | TOFACITINIB | Macleods Pharmaceuticals Limited | 9b654f0d-7705-4880-9e9d-ad3a51e56b56 | 2026-10-22 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| TOFACITINIB CITRATE | TOFACITINIB CITRATE | Stellon Biotech Inc. | 89eb2ffc-02d9-4b46-b480-e9b10af33027 | 2026-10-16 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| TOFACITINIB | TOFACITINIB | Sun Pharmaceutical Industries, Inc. | a764a133-b870-4514-bbee-24d43f8cb7fd | 2026-10-16 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| TOFACITINIB CITRATE | TOFACITINIB CITRATE | CONCORD BIOTECH LIMITED | 6c33e5b4-4843-4a80-a4f8-435bfceddc2a | 2026-10-16 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| Tofacitinib | TOFACITINIB | Saptalis Pharmaceuticals, LLC. | c6c033ff-bce0-4d1c-a182-3b13191686e1 | 2026-10-15 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| Artificial Tears | GLYCERIN | Preferred Pharmaceuticals Inc. | dd646c72-8f47-43c6-a734-db0dcc8cd4d1 | 2026-10-14 | Warnings | 3NXW29V3WO |
| TOFACITINIB CITRATE | TOFACITINIB CITRATE | Golden State Medical Supply, Inc. | 5dd43533-dadc-2acb-e063-6394a90a413f | 2026-10-14 | Boxed warning, Warnings, Adverse reactions | 1741046 O1FF4DIV0D |
| tofacitinib | TOFACITINIB | Zydus Pharmaceuticals USA Inc. | 179ffbb2-bedc-40e6-b77b-33d4f7832172 | 2026-10-09 | Boxed warning, Warnings, Adverse reactions | 1741046 O1FF4DIV0D |
| Tofacitinib | TOFACITINIB | Apotex Corp. | dd62a2b8-300b-d92b-7b27-a30eaa68fdd3 | 2026-10-08 | Boxed warning, Warnings, Adverse reactions | ANDA220458 60505-4858-3 60505-4858 60505485803 1741046 cca6e2e3-13e4-2ab5-5750-4a62f654355e dd62a2b8-300b-d92b-7b27-a30eaa68fdd3 O1FF4DIV0D |
| Tofacitinib XR | TOFACITINIB | Biocon Pharma Inc | f0160e3d-63ea-75fb-4b88-fe3d6a6ce030 | 2026-10-07 | Boxed warning, Warnings, Adverse reactions | 1741046 O1FF4DIV0D |
| XELJANZ | TOFACITINIB | U.S. Pharmaceuticals | 68e3d6b2-7838-4d2d-a417-09d919b43e13 | 2026-10-06 | Boxed warning, Warnings, Adverse reactions | 1741046 O1FF4DIV0D |
| Tofacitinib | TOFACITINIB | Ajanta Pharma USA Inc. | 024bb9f2-8c26-4d9d-a33b-eb3c0a7c59ed | 2026-10-05 | Boxed warning, Warnings, Adverse reactions | 1741046 O1FF4DIV0D |
| tofacitinib | TOFACITINIB | Zydus Pharmaceuticals USA Inc. | 21a89264-8047-40ac-8b10-fa6461072509 | 2026-10-05 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| TOFACITINIB | TOFACITINIB | Bryant Ranch Prepack | 89211a4d-befb-40f1-8792-aa599fdd794c | 2026-10-02 | Boxed warning, Warnings, Adverse reactions | 1741046 O1FF4DIV0D |
| TOFACITINIB | TOFACITINIB | Micro Labs Limited | ffa6819b-23a4-478b-8fb7-cc90e8142fc5 | 2026-09-25 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| tofacitinib solution | TOFACITINIB | Hikma Pharmaceuticals USA Inc. | d9cf18a9-e825-49ac-b080-68957c0e79ae | 2026-09-24 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| Lymph Tonic II | ECHINACEA (ANGUSTIFOLIA), COLLINSONIA CANADENSIS, PHYTOLACCA DECANDRA, KALI IODATUM, PINUS SYLVESTRIS, PIX LIQUIDA, FERRUM PHOSPHORICUM, AESCULUS HIPPOCASTANUM, BARYTA CARBONICA, BERBERIS VULGARIS, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, CAUSTICUM, HEPAR SULPHURIS CALCAREUM, KREOSOTUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, NITRICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SILICEA, STELLARIA MEDIA, SULPHUR, TEREBINTHINA, THUJA OCCIDENTALIS, BUFO RANA | BioActive Nutritional, Inc. | 0e3265b0-b210-4a4c-80d2-8a9712981d4e | 2026-09-17 | Warnings | ETJ7Z6XBU4 |
| Psoriasis Control | CENTELLA ASIATICA, SODIUM CHLORIDE, AND SILICON DIOXIDE | Forces of Nature | 2db33771-0bb9-49f8-84fa-dddc28e4ba26 | 2026-09-04 | Warnings | ETJ7Z6XBU4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.